Last reviewed · How we verify
Dextrose 5% in water bilateral injection
Dextrose 5% in water provides intravenous hydration and a source of glucose for systemic energy metabolism.
Dextrose 5% in water provides intravenous hydration and a source of glucose for systemic energy metabolism. Used for Dehydration and fluid replacement, Hypoglycemia management, Provision of calories in patients unable to take oral nutrition.
At a glance
| Generic name | Dextrose 5% in water bilateral injection |
|---|---|
| Sponsor | Dr. Dean Reeves Clinic |
| Drug class | Intravenous fluid / Carbohydrate solution |
| Modality | Small molecule |
| Therapeutic area | Supportive Care / Fluid & Electrolyte Management |
| Phase | FDA-approved |
Mechanism of action
This is a basic intravenous fluid formulation that delivers water and dextrose (glucose) directly into the bloodstream. It serves dual purposes: rehydration of patients with fluid deficits and provision of carbohydrate calories for metabolic support. The dextrose is rapidly metabolized for energy, while the hypotonic nature of the solution promotes cellular hydration.
Approved indications
- Dehydration and fluid replacement
- Hypoglycemia management
- Provision of calories in patients unable to take oral nutrition
- Maintenance fluid therapy
Common side effects
- Hyperglycemia
- Phlebitis at injection site
- Hyponatremia (with excessive administration)
- Fluid overload
Key clinical trials
- Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD (PHASE4)
- The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS)Applied on Cardiac Surgery With Cardiopulmonary Bypass (PHASE2)
- The Effect of Mixed Exercise and Metabolic Stress in Relationship to Age in Healthy Men (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: